TNFSF11 and diabetes mellitus: A close correlation between receptor activator of nuclear factor κB ligand (RANKL) inhibition and improved glucose metabolism has previously been proposed.11 Low-grade inflammation is associated with the onset of insulin resistance and diabetes.